Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding. 1985

E Dejana, and L R Languino, and N Polentarutti, and G Balconi, and J J Ryckewaert, and M J Larrieu, and M B Donati, and A Mantovani, and G Marguerie

It has been suggested that fibrinogen (fg) or its physiological derivatives influence the motility and growth of endothelial cells (ECs), but direct support for this concept is still lacking. In the present study, the capacity of fg to interact with ECs and induce the migration of ECs was examined. The capacity of fg to induce EC migration was studied by means of a modification of the Boyden chamber technique. fg in the lower compartment of the chamber caused a time- and concentration-dependent migration of ECs across filters. fg present in equal concentrations above and below the filter increased EC migration, but the maximal effect invariably occurred in the presence of a gradient between the lower and the upper compartments. Trypsin or plasmin digestion of fg and preincubation of fg with Fab fragments from specific antibody completely abolished fg-induced EC migration. Dialysis of fg to eliminate small peptides that might contaminate the preparation did not modify fg-induced migration. Plasma obtained from healthy donors induced EC migration, but plasma from an afibrinogenemic patient was completely ineffective. The addition of purified fg to afibrinogenemic plasma restored plasma-induced EC migration. Plasmin degradation fragments D and E, of 100,000 and 50,000 mol wt, respectively, did not induce EC migration. However, fragment E caused dose-related inhibition of fg-induced EC migration Direct interaction of highly purified radioiodinated human fg with cultured human and bovine Ecs was observed. The binding was time dependent and plateaued at 10 min. Nonlabeled fg in a large molar excess inhibited the interaction, but unrelated proteins, including fibronectin, ovalbumin, and myoglobin, did not. Monospecific Fab fragments directed to fg inhibited binding by 38% at a 50 to 1 molar ratio whereas nonimmune Fab caused only 2% inhibition at a similar concentration. The binding of 125I-fg with ECs was saturable, and an apparent dissociation constant of 0.23 x 10(-6) M was estimated from binding isotherms. After 30 min of incubation the interaction between 125I-fg and the cells was completely reversible and displaceable by a large molar excess of unlabeled fg. Autoradiography of the display of EC-bound 125I on polyacrylamide gel showed the constitutive B beta- and gamma-chains of the fg molecule, with a partial loss of the A alpha-chain. Purified fragment E and E were tested for their capacity to inhibit fg binding. At a 1 to 400 125I-fg-to-fragment molar ratio, fragment E, which also inhibited migration, competed for binding by 44%, but fragment D was completely ineffective. These data show that fg may specifically associate with ECs and induce migration of these cells; it also appears that the structural requirement of this activity is located in the N-terminal part of the molecule.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D002633 Chemotaxis The movement of cells or organisms toward or away from a substance in response to its concentration gradient. Haptotaxis
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D004727 Endothelium A layer of epithelium that lines the heart, blood vessels (ENDOTHELIUM, VASCULAR), lymph vessels (ENDOTHELIUM, LYMPHATIC), and the serous cavities of the body. Endotheliums
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

E Dejana, and L R Languino, and N Polentarutti, and G Balconi, and J J Ryckewaert, and M J Larrieu, and M B Donati, and A Mantovani, and G Marguerie
February 1985, Thrombosis and haemostasis,
E Dejana, and L R Languino, and N Polentarutti, and G Balconi, and J J Ryckewaert, and M J Larrieu, and M B Donati, and A Mantovani, and G Marguerie
August 1988, European journal of immunology,
E Dejana, and L R Languino, and N Polentarutti, and G Balconi, and J J Ryckewaert, and M J Larrieu, and M B Donati, and A Mantovani, and G Marguerie
July 1983, Atherosclerosis,
E Dejana, and L R Languino, and N Polentarutti, and G Balconi, and J J Ryckewaert, and M J Larrieu, and M B Donati, and A Mantovani, and G Marguerie
January 1985, Journal of cellular physiology,
E Dejana, and L R Languino, and N Polentarutti, and G Balconi, and J J Ryckewaert, and M J Larrieu, and M B Donati, and A Mantovani, and G Marguerie
July 1988, The Journal of laboratory and clinical medicine,
E Dejana, and L R Languino, and N Polentarutti, and G Balconi, and J J Ryckewaert, and M J Larrieu, and M B Donati, and A Mantovani, and G Marguerie
February 1997, Blood,
E Dejana, and L R Languino, and N Polentarutti, and G Balconi, and J J Ryckewaert, and M J Larrieu, and M B Donati, and A Mantovani, and G Marguerie
February 2003, Hypertension research : official journal of the Japanese Society of Hypertension,
E Dejana, and L R Languino, and N Polentarutti, and G Balconi, and J J Ryckewaert, and M J Larrieu, and M B Donati, and A Mantovani, and G Marguerie
January 1988, Haemostasis,
E Dejana, and L R Languino, and N Polentarutti, and G Balconi, and J J Ryckewaert, and M J Larrieu, and M B Donati, and A Mantovani, and G Marguerie
April 1996, Biochemical and biophysical research communications,
E Dejana, and L R Languino, and N Polentarutti, and G Balconi, and J J Ryckewaert, and M J Larrieu, and M B Donati, and A Mantovani, and G Marguerie
November 1987, Journal of applied physiology (Bethesda, Md. : 1985),
Copied contents to your clipboard!